Physician profile
Clair Bello
NPI 1518960855
$6,042.32
in general payments reported to CMS, 2019-2025
30 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,080 · 2020: $219 · 2021: $1,522 · 2022: $1,092 · 2023: $718 · 2024: $891 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,128.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,277.66 | 2021-2024 | Phantom Hindfoot |
| Smith+Nephew, INC. | $1,101.44 | 2019-2025 | Oasis, Stravix, Grafix |
| Wright Medical Technology, INC. | $745.77 | 2019 | |
| Organogenesis INC. | $531.10 | 2021-2024 | |
| Abbvie INC. | $310.82 | 2021-2024 | Dalvance, Teflaro |
| Stryker Corporation | $298.00 | 2023-2025 | Salvation, Augment Injectable, Ortholoc 2 Lapifuse |
| Smoky Mountain Surgical LLC | $225.33 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $199.06 | 2020-2024 | Nuzyra |
| Medtronic, INC. | $167.30 | 2022 | |
| Depuy Synthes Sales INC. | $149.21 | 2023-2025 | Lcp, Crosstie, Motoband |
| Treace Medical Concepts, INC. | $110.96 | 2022 | |
| Averitas Pharma INC. | $109.99 | 2023 | Qutenza |
| Zimvie INC. | $109.00 | 2023 | |
| Kerecis Limited | $77.77 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Linvatec Corporation | $67.22 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $64.06 | 2024-2025 | Cmf |
| Medartis INC. | $58.44 | 2019-2020 | |
| Amniox Medical, INC. | $57.83 | 2020 | |
| Cardiovascular Systems INC. | $52.03 | 2019 | |
| Horizon Therapeutics Plc | $47.77 | 2019-2023 | Krystexxa |
| Terumo Medical Corporation | $45.34 | 2019 | |
| Medical Device Business Services, INC. | $43.88 | 2020 | |
| Bioventus LLC | $41.11 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $30.82 | 2022 | |
| Trice Medical, INC. | $27.50 | 2022 | |
| Nevro Corp. | $24.00 | 2024 | Senza |
| Amgen INC. | $21.70 | 2024 | Krystexxa |
| Aroa Biosurgery Incorporated | $19.24 | 2020 | |
| Koya Medical, INC. | $14.56 | 2025 | Dayspring, Koya Medical |
| Sanara Medtech INC. | $13.41 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clair Bello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.